Figure 1.

Trends of mean Hb (A), ARC (B), and CHr (C) (y-axis) in early responding patients and not early responding patients at diagnosis (T0), within 7 days from the beginning of oral iron supplementation (T7), and after 30 days (T30) (x-axis) (5, 6).